Literature DB >> 8034999

Endocarditis due to high level gentamicin resistant Enterococcus faecium.

S S Das1, J R Anderson, A A Macdonald, K W Somerville.   

Abstract

We describe the first reported case in the literature of bacterial endocarditis caused by Enterococcus faecium that was highly resistant to gentamicin. The case is unusual in that it followed a successfully treated Streptococcus sanguis endocarditis. The micro-organism was susceptible only to the glycopeptide antibiotics, vancomycin and teicoplanin and to agents such as pristinamycin and daptomycin which are not routinely available for treatment. It illustrates the therapeutic dilemma posed by serious infections with such micro-organisms and supports previous observations that early heart valve replacement surgery may be necessary to achieve cure of endocarditis due to enterococci which are highly resistant to gentamicin. It further emphasises the importance of screening for high-level aminoglycoside resistance in enterococci in all life threatening enterococcal infections, including endocarditis, septicaemia and meningitis when aminoglycoside-penicillin synergy is required for successful treatment.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034999     DOI: 10.1016/s0163-4453(94)95680-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Activity of daptomycin or linezolid in combination with rifampin or gentamicin against biofilm-forming Enterococcus faecalis or E. faecium in an in vitro pharmacodynamic model using simulated endocardial vegetations and an in vivo survival assay using Galleria mellonella larvae.

Authors:  Megan K Luther; Marios Arvanitis; Eleftherios Mylonakis; Kerry L LaPlante
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

2.  Efficacy of ampicillin plus ceftriaxone in treatment of experimental endocarditis due to Enterococcus faecalis strains highly resistant to aminoglycosides.

Authors:  J Gavaldà; C Torres; C Tenorio; P López; M Zaragoza; J A Capdevila; B Almirante; F Ruiz; N Borrell; X Gomis; C Pigrau; F Baquero; A Pahissa
Journal:  Antimicrob Agents Chemother       Date:  1999-03       Impact factor: 5.191

Review 3.  Streptogramins and their potential role in geriatric medicine.

Authors:  B M Lomaestro; L L Briceland
Journal:  Drugs Aging       Date:  1998-12       Impact factor: 3.923

Review 4.  Daptomycin: a cyclic lipopeptide antimicrobial agent.

Authors:  LilyAnn Jeu; Horatio B Fung
Journal:  Clin Ther       Date:  2004-11       Impact factor: 3.393

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.